MAPK8 and chronic myelogenous leukemia, BCR-ABL1 positive: Although the signaling partners Ras and Jnk have been implicated as important downstream effectors of BCR-ABL driven CML [35] [36], no difference in the activation status of either Ras or Jnk pathways was observed (data not shown).